Sangiovanni Timothy J.

Sangiovanni Timothy J. is listed in filings as SVP at Zevra Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including sale activity. Recent filings connect the profile to Zevra Therapeutics, Inc. (ZVRA). The current snapshot covers public activity from Feb 3, 2025 to May 29, 2026. Reported amounts are shown as $304.8K to $15.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.